Literature DB >> 15555886

Efficacy of the latest fluoroquinolones against experimental Yersinia pestis.

J Steward1, M S Lever, P Russell, R J Beedham, A J Stagg, R R Taylor, T J G Brooks.   

Abstract

The efficacies of prophylactic and therapeutic gatifloxacin and moxifloxacin were assessed in a BALB/c mouse model of systemic and pneumonic plague and compared with ciprofloxacin. Mice were given 100 mg/kg of the antibiotic by oral administration twice daily for 7 days starting 1h prior to infection or following infection. All antibiotics offered full protection for up to 6h following systemic challenge, and for up to 30 h following an aerosol challenge. The efficacy of each of the antibiotics decreased when antibiotics were started 18 h following systemic challenge and 48 h following aerosol challenge. Fluoroquinolones may therefore be considered useful candidates for the treatment of bubonic and pneumonic plague.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15555886     DOI: 10.1016/j.ijantimicag.2004.06.011

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  10 in total

Review 1.  Resistance of Yersinia pestis to antimicrobial agents.

Authors:  Marc Galimand; Elisabeth Carniel; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

2.  Comparative efficacies of candidate antibiotics against Yersinia pestis in an in vitro pharmacodynamic model.

Authors:  Arnold Louie; Brian Vanscoy; Weiguo Liu; Robert Kulawy; David Brown; Henry S Heine; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2011-04-12       Impact factor: 5.191

3.  Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance.

Authors:  A Louie; H S Heine; B VanScoy; A Eichas; K Files; S Fikes; D L Brown; W Liu; M Kinzig-Schippers; F Sörgel; G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2010-11-29       Impact factor: 5.191

4.  Lack of antimicrobial resistance in Yersinia pestis isolates from 17 countries in the Americas, Africa, and Asia.

Authors:  Sandra K Urich; Linda Chalcraft; Martin E Schriefer; Brook M Yockey; Jeannine M Petersen
Journal:  Antimicrob Agents Chemother       Date:  2011-10-24       Impact factor: 5.191

Review 5.  Plague gives surprises in the first decade of the 21st century in the United States and worldwide.

Authors:  Thomas Butler
Journal:  Am J Trop Med Hyg       Date:  2013-09-16       Impact factor: 2.345

6.  Different pathologies but equal levels of responsiveness to the recombinant F1 and V antigen vaccine and ciprofloxacin in a murine model of plague caused by small- and large-particle aerosols.

Authors:  Richard J Thomas; Daniel Webber; Aaron Collinge; Anthony J Stagg; Stephen C Bailey; Alejandro Nunez; Amanda Gates; Pramukh N Jayasekera; Rosa R Taylor; Steve Eley; Richard W Titball
Journal:  Infect Immun       Date:  2009-02-02       Impact factor: 3.441

7.  Protection Afforded by Fluoroquinolones in Animal Models of Respiratory Infections with Bacillus anthracis, Yersinia pestis, and Francisella tularensis.

Authors:  Johnny W Peterson; Scott T Moen; Daniel Healy; Jennifer E Pawlik; Joanna Taormina; Jason Hardcastle; John M Thomas; William S Lawrence; Cindy Ponce; Bagram M Chatuev; Bryan T Gnade; Sheri M Foltz; Stacy L Agar; Jian Sha; Gary R Klimpel; Michelle L Kirtley; Tonyia Eaves-Pyles; Ashok K Chopra
Journal:  Open Microbiol J       Date:  2010-06-03

8.  Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.

Authors:  Nadine Lemaître; Xiaofei Liang; Javaria Najeeb; Chul-Jin Lee; Marie Titecat; Emmanuelle Leteurtre; Michel Simonet; Eric J Toone; Pei Zhou; Florent Sebbane
Journal:  MBio       Date:  2017-07-25       Impact factor: 7.867

Review 9.  Antibiotic Therapy of Plague: A Review.

Authors:  Florent Sebbane; Nadine Lemaître
Journal:  Biomolecules       Date:  2021-05-12

10.  Can phage effectively treat multidrug-resistant plague?

Authors:  Andrey A Filippov; Kirill V Sergueev; Mikeljon P Nikolich
Journal:  Bacteriophage       Date:  2012-07-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.